“FREQUENCY AND CHARACTERISTICS OF ADVERSE EVENTS ASSOCIATED WITH ANTI-TUBERCULOSIS DRUGS DURING THE TREATMENT OF DRUG-RESISTANT PULMONARY TUBERCULOSIS”. Eureka Journal of Health Sciences & Medical Innovation 2, no. 6 (June 8, 2026): 1–11. Accessed June 16, 2026. https://eurekaoa.com/index.php/5/article/view/1148.